Establishment of a high-fidelity patient-derived xenograft model for cervical cancer enables the evaluation of patient’s response to conventional and novel therapies

BACKGROUND: Recurrent or metastatic cervical cancer (r/m CC) often has poor prognosis owing to its limited treatment options. The development of novel therapeutic strategies has been hindered by the lack of preclinical models that accurately reflect the biological and genomic heterogeneity of cervic...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Liting, Wu, Min, Huang, Anni, Gao, Chun, Yang, Yifan, Liu, Hong, Jiang, Han, Yu, Long, Huang, Yafei, Wang, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492358/
https://www.ncbi.nlm.nih.gov/pubmed/37689699
http://dx.doi.org/10.1186/s12967-023-04444-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492358/
https://www.ncbi.nlm.nih.gov/pubmed/37689699
http://dx.doi.org/10.1186/s12967-023-04444-5

Ejemplares similares